![[6-Hydroxy-2-(4-hydroxyphenyl)-7-[4-(2-piperidin-1-yl-ethoxy)benzoyl]-benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methano ne](https://static.cymitquimica.com/products/3D/img/IH45164.png "Clique para ampliar")
[6-Hydroxy-2-(4-hydroxyphenyl)-7-[4-(2-piperidin-1-yl-ethoxy)benzoyl]-benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methano ne
CAS: 1159977-58-8
Ref. 3D-IH45164
| 1mg | A consultar | |
| 2mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar |
Informação sobre produto
- Raloxifene impurity I7-[4-(2-Piperidinyl)ethoxy]benzoyl raloxifene
(6-Hydroxy-2-(4-hydroxyphenyl)-7-[4-(2-piperidin-1-yl-ethoxy)benzoyl]-benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methano ne) is a synthetic drug product that has been custom synthesized for the purpose of research and development. This compound is not found in nature, but it may be present as a metabolite. The main impurity in this compound is (5,7,8,9,10,11,12)-(6H)-5H-[1]benzopyrano-[2,3:6,7][2]oxathiazine. Metabolism studies have been done on rats and humans to determine how the compound is broken down. It was determined that the liver enzyme CYP3A4 was responsible for the
Propriedades químicas
Consulta técnica sobre: 3D-IH45164 [6-Hydroxy-2-(4-hydroxyphenyl)-7-[4-(2-piperidin-1-yl-ethoxy)benzoyl]-benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methano ne
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
